Literature DB >> 22010021

Gastric cancer: Nagoya is not New York.

John S Macdonald.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22010021     DOI： 10.1200/JCO.2011.37.5691

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

1.  Gastrointestinal cancer: Adjuvant chemotherapy after D2 gastrectomy for gastric cancer.

Authors:  Takaki Yoshikawa; Mitsuru Sasako
Journal:  Nat Rev Clin Oncol       Date:  2012-02-28       Impact factor: 66.675

2.  Is Sarcopenic Obesity an Indicator of Poor Prognosis in Gastric Cancer Surgery? A Cohort Study in a Western Population.

Authors:  V Rodrigues; F Landi; S Castro; R Mast; N Rodríguez; A Gantxegi; J Pradell; M López-Cano; M Armengol
Journal:  J Gastrointest Surg       Date:  2020-07-13       Impact factor: 3.452

Review 3.  Next generation sequencing in gastric or gastroesophageal adenocarcinoma.

Authors:  Geoffrey Y Ku
Journal:  Transl Gastroenterol Hepatol       Date:  2020-10-05

4.  Gastrectomy with Extended Lymphadenectomy: a North American Perspective.

Authors:  Alexandre Gosselin-Tardif; Jessica Lie; Ioana Nicolau; Juan Carlos Molina; Jonathan Cools-Lartigue; Liane Feldman; Jonathan Spicer; Carmen Mueller; Lorenzo Ferri
Journal:  J Gastrointest Surg       Date:  2017-11-09       Impact factor: 3.452

5.  Prognosis of Young Survivors of Gastric Cancer in China and the U.S.: Determining Long-Term Outcomes Based on Conditional Survival.

Authors:  Qi-Yue Chen; Qing Zhong; Wei Wang; Shi Chen; Ping Li; Jian-Wei Xie; Jia-Bing Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Hua-Long Zheng; Zhi-Yu Liu; Chao-Hui Zheng; Jun-Sheng Peng; Zhi-Wei Zhou; Chang-Ming Huang
Journal:  Oncologist       Date:  2018-11-23

Review 6.  Novel therapies for metastatic renal cell carcinoma: efforts to expand beyond the VEGF/mTOR signaling paradigm.

Authors:  Sumanta Kumar Pal; Stephen Williams; David Y Josephson; Courtney Carmichael; Nicholas J Vogelzang; David I Quinn
Journal:  Mol Cancer Ther       Date:  2012-02-17       Impact factor: 6.261

7.  Adjuvant therapy in esophagogastric adenocarcinoma: controversies and consensus.

Authors:  Geoffrey Y Ku; David H Ilson
Journal:  Gastrointest Cancer Res       Date:  2012-05

Review 8.  Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward.

Authors:  Konstantinos Papadimitriou; Georgios Antoniou; Christian Rolfo; Antonio Russo; Giuseppe Bronte; Vassilios Vassiliou; Demetris Papamichael; Marc Peeters; Panteleimon Kountourakis
Journal:  Gastroenterol Res Pract       Date:  2015-05-26       Impact factor: 2.260

Review 9.  Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care.

Authors:  Amikar Sehdev; Daniel V T Catenacci
Journal:  J Hematol Oncol       Date:  2013-09-05       Impact factor: 17.388

10.  A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology.

Authors:  Jun Ho Yi; Jung Hun Kang; In Gyu Hwang; Hee Kyung Ahn; Hyun Jin Baek; Soon Il Lee; Do Hyoung Lim; Young-Woong Won; Jun Ho Ji; Hyo Song Kim; Sun Young Rha; Sung Yong Oh; Kyung Eun Lee; Taekyu Lim; Chi Hoon Maeng; Moon Jin Kim; Seung Tae Kim; Jeeyun Lee; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Se Hoon Park
Journal:  Cancer Res Treat       Date:  2015-08-10       Impact factor: 4.679
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.